You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background
The Clock Drawing Test (CDT) is a widely used neuropsychological tool and a component of the Toronto Cognitive Assessment (TorCA). We aimed to determine whether specific CDT sub‐scores predict performance on other TorCA sub‐tests. Identifying such relationships may support removal of measures, thereby reducing overall TorCA administration time.
Method
Data were obtained from the Toronto Dementia Research Alliance database which includes patient demographic and clinical information assessed at four Toronto area memory clinics. Performance on the CDT is based upon 4 sub‐scores: contour, numbers, hands, and centre. The TorCA contains 24 sub‐tests in addition to the CDT that evaluate cognitive domains including memory, visuospatial, working memory/attention/executive control, and language. To identify a linear combination of CDT sub‐scores that is maximally associated with a linear combination of the other TorCA sub‐tests, we used singular value decomposition of their cross‐block correlation matrix as applied by Partial Least Squares. Reported saliences describe relative contributions of each variable to the linear combinations. Saliences greater than 2 standard errors (se) are considered significant.
Result
CDT and TorCA sub‐test saliences using data from 1,872 participants are presented in Figure 1. The “hand” sub‐score returned relatively large salience (0.71, se = 0.31). The “numbers” sub‐score had slightly lower salience (0.50, se = 0.22); the “centre” sub‐score returned a similar salience (0.43, se = 0.19). TorCA sub‐tests of working memory/attention/executive control, semantic knowledge, and visuospatial function returned larger saliences (Figure 1). Specifically, the strongest association was with Trails B (0.33, se = 0.15), followed by Trails A (0.27, se = 0.13), semantic fluency (0.25, se = 0.11), Benson Figure copy (0.25, se = 0.12) and recall (0.25, se = 0.11).
Conclusion
Within the CDT scoring system, clock hands and numbers were the strongest predictors of performance on the TorCA sub‐tests. The most robust associations were with domains of working memory/attention/executive function, semantic knowledge, and visuospatial function. We plan to apply artificial intelligence to classify clocks based on these cognitive functions. We will then examine how these classified clocks relate to TorCA sub‐tests to determine whether redundant tests could be removed, thereby shortening administration time.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Baycrest Health Sciences, Toronto, ON, Canada, University of Toronto, Toronto, ON, Canada
2 Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, Rotman Research Institute, Baycrest Academy for Research and Education, Toronto, ON, Canada, Baycrest Academy for Research and Education, Toronto, ON, Canada
3 University of Toronto, Toronto, ON, Canada, Sunnybrook Research Institute, Toronto, ON, Canada, Toronto Dementia Research Alliance, Toronto, ON, Canada
4 University of Toronto, Toronto, ON, Canada, Toronto Dementia Research Alliance, Toronto, ON, Canada, Centre for Addiction and Mental Health, Toronto, ON, Canada
5 Toronto Dementia Research Alliance, Toronto, ON, Canada, Department of Medicine, University of Toronto, Toronto, ON, Canada, Memory Clinic, Toronto Western Hospital, University Health Network, Toronto, ON, Canada
6 Memory Clinic, Toronto Western Hospital, University Health Network, Toronto, ON, Canada, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada, Toronto Dementia Research Alliance (TDRA), Toronto, ON, Canada
7 Baycrest Health Sciences, Toronto, ON, Canada, University of Toronto, Toronto, ON, Canada, Toronto Dementia Research Alliance, Toronto, ON, Canada, Mt. Sinai Hospital, Toronto, ON, Canada, Rotman Research Institute at Baycrest, Toronto, ON, Canada, Rotman Research Institute, Baycrest Health Sciences, Toronto, ON, Canada





